Search Results 441-450 of 1939 for ⚕보급형 ARP프로토콜 노후투자 확장성이좋다⚕
Sponsor Protocol Number: 17-007947. About this study. The purpose of this study is to evaluate the cardiovascular properties of MANP in African Americans (AA) ...
Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in ...
About this study. This study will enroll approximately 460 subjects, aged 55 or older, with a diagnosis of de novo AML (Acute Myeloid Leukemia) or AML ...
The purpose of this study is to determine the accuracy of an automated non-invasive arterial pressure device when assessing people with peripheral arterial ...
The purpose of this study is to evaluate the effectiveness, safety, tolerability and immunogenicity (ability to produce immune response) of INO-3107 in ...
Sponsor Protocol Number: EA2185. About this study. The purpose of this study is to compare the two approaches for monitoring pancreatic cysts - more frequent ...
The purpose of this study is to provide patients with Dravet Syndrome, who do not qualify for participation in one of the ongoing ZX008 clinical trials, to ...
About this study. Multicenter, randomized, assessor-blinded controlled study of safety and effectiveness of the PneumRx, Inc. RePneu Lung Volume Reduction ...
Mangafodipir is given by injection before MRI to help diagnose problems in the liver. Mangafodipir is injected into a vein. The dose of this agent will be ...
Sponsor Protocol Number: 12-008053. About this study. If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.